Home › Funds › Two Sigma Investments › NRXP
Two Sigma Investments position in NRXP
NRX PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)26.43K sh
Reported value held$108.09K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 41.45K | $25.00K | New |
| Q1 2025 | 30.15K | $61.80K | New |
| Q1 2025 | 30.15K | $61.80K | New |
| Q2 2025 | 31.45K | $102.53K | Add |
| Q2 2025 | 31.45K | $102.53K | Add |
| Q3 2025 | 52.33K | $172.70K | Add |
| Q4 2025 | 17.44K | $47.25K | Reduce |
| Q2 2026 | 26.43K | $108.09K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRXP
- Balyasny Asset Management 893.86K sh · $3.66M · Q2 2026
- Vanguard Group 729.84K sh · $1.98M · Q4 2025
- UBS Group AG 423.12K sh · $1.73M · Q2 2026
- Geode Capital Management 314.66K sh · $1.29M · Q2 2026
- BlackRock Inc 220.46K sh · $901.68K · Q2 2026
- Marshall Wace 194.58K sh · $795.83K · Q2 2026
- Northern Trust Corp 62.95K sh · $257.47K · Q2 2026
- Morgan Stanley 40.90K sh · $167.28K · Q2 2026
- Renaissance Technologies 38.60K sh · $157.87K · Q2 2026
- Citadel Advisors 26.70K sh · $109.20K · Q2 2026
- Millennium Management 12.30K sh · $50.33K · Q2 2026